The evidence leans constructive8 supporting, 0 against, 1 worth knowing
Supporting
trading 117% above its 200-day average
sitting at 96% of its 52-week range, with little overhead supply from trapped buyers
up 342% over twelve months
matches growing fast and near a high, which has beaten the market by +0.97 points over 20 sessions across 15,457 past signals
6 of the scans it matches have a positive measured record
6 independent kinds of evidence agree today, which is uncommon
revenue grew 38% year on year in the quarter ending 30 June 2026
net margin has widened from 11.7% to 18.0% across four quarters
Against
nothing the data supports either way
Worth knowing
RSI at 74 is stretched; strong stocks stay stretched for a long time, so this is a note on entry timing, not on direction
What would change this read: a close below 323, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working5
Revenue rose 37.6% year on year, from Rs 207 cr to Rs 286 cr.
+37.6%Rs 207 crRs 286 cr
Net profit rose 15.8% year on year, from Rs 44 cr to Rs 51 cr.
+15.8%Rs 44 crRs 51 cr
Trading 116.9% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+116.9%
Up 341.5% over the past year.
+341.5%
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching3
Net margin moved from 21.4% to 18.0%.
21.4%18.0%
Profit grew slower than revenue, +15.8% against +37.6%.
+15.8%+37.6%
A warning rule fires on it tonight: stretched far above trend.
Stretched far above trend
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 4 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
11 of 47 matched on 10 Sep
BLISSGVS matches 11 of the 47 scans today, across 6 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
BLISSGVS trades at 52× trailing earnings, above its median of 19× over this window — 183% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 38% against the same quarter a year earlier
profit rose 16% year on year
net margin widened from 14.4% to 18.0%
revenue rose in 3 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
286
75
51
4.73
18.0%
Q4 FY26
31 Mar · consolidated
257
45
37
3.37
14.4%
Q3 FY26
31 Dec · consolidated
218
41
25
2.20
11.4%
Q2 FY26
30 Sep · consolidated
244
41
29
2.58
11.7%
Q1 FY26
30 Jun · consolidated
207
63
44
4.08
21.4%
Q4 FY25
31 Mar · consolidated
198
23
17
1.47
8.4%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+30.6%
Versus 200-day average+116.9%
Below 52-week high-3.0%
Above 52-week low+446.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)73.8
Higher closes in last 54 of 5
Six-month return+242.52%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.88%
Volume versus 20-day0.5x
Median daily turnoverRs 23.9 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
10 Sep
2
The market's strongest stocks, Beating the market for 6 months
9 Sep
2
The market's strongest stocks, Beating the market for 6 months
8 Sep
4
The market's strongest stocks, Beating the market for 6 months, Above the 200-day EMA, Gapped up and held it
7 Sep
3
The market's strongest stocks, Beating the market for 6 months, Above the 200-day EMA
4 Sep
3
The market's strongest stocks, Beating the market for 6 months, Closed at the day's high
3 Sep
2
The market's strongest stocks, Beating the market for 6 months
2 Sep
3
The market's strongest stocks, Beating the market for 6 months, Above the 200-day EMA
1 Sep
2
The market's strongest stocks, Beating the market for 6 months
31 Aug
2
The market's strongest stocks, Beating the market for 6 months